mcp4 Thursday, 04/19/18 01:26:03 PM Re: None Post # of 41 ROCK2 inhibitor KD025 was approved for Phase II clinical trials in Chronic Graft-Versus-Host Disease Pivotal Clinical Trial Design for KD025 in cGVHD